Share |

FDA Update: Osteoporosis Drugs and Fracture Risks

Posted on 22. Mar, 2010 by in Clinical Notes

3 items for your facility’s medication management action plan for patients taking Fosamax, Actonel, Boniva, and Reclast

The Food and Drug Administration is warning the public about the possibly raised fracture risks for patients with osteoporosis who take bisphosphonate drugs,...

Click here to login and get access to this article if you already receive the Long Term Care Wire
If you've already signed in and are still seeing this screen, click here to refresh the page.
Long Term Care News Wire
Free registration required for full access to articles.
You will also receive
  • Archive of MDS pointers, searchable by keyword or quality measure.
  • Staff training materials that help your SNF ace its surveys.
  • Training and implementation tools for MDS 3.0.
Join now
You must have javascript enabled to use this form
Bookmark and Share

Tags: , , , , ,